N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population

CONTEXT: Somatostatin inhibits a range of hormones, including GH, insulin, and glucagon, but little is known about its role in the development of cardiometabolic disease. OBJECTIVE: The objective of the study was to investigate whether fasting plasma concentration of N-terminal prosomatostatin (NT-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedbäck, Tore, Almgren, Peter, Nilsson, Peter M., Melander, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010564/
https://www.ncbi.nlm.nih.gov/pubmed/27399347
http://dx.doi.org/10.1210/jc.2016-1736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010564/
https://www.ncbi.nlm.nih.gov/pubmed/27399347
http://dx.doi.org/10.1210/jc.2016-1736

Ejemplares similares